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Abstract
Replacement of a single dA nucleotide positioned at a programmed site in a DNA plasmid with its
7-deaza-analog is described together with its complete resistance to restriction enzymatic
cleavage.
Protein-DNA recognition is a fundamental biomolecular interaction that drives critical
cellular processes responsible for life. The ability to recognize specific DNA sequences
within the vast genome, as the first step to deciphering the encoded genetic information, is
critical for the timely expression of genes as proteins and cellular survival.1 In order to gain
insights into the nature of these interactions, well-defined and representative DNA substrates
containing site-specific modifications are required as probes and they are technically
challenging to prepare. We are currently exploring strategies for generating plasmid DNA
vectors containing single platinated-DNA adducts that can transfected into live mammalian
cells for subsequent functional studies.2 During the course of this work, we carried out a
single atom modification on a plasmid by replacing a N7 atom on the heterocyclic ring of a
single deoxyadenosine residue with a C–H unit. We report here that this conversion is
sufficient to completely abrogate restriction enzyme function.
The methodology described in this communication improves upon a protocol previously
described.2 The approach involves formation of a site-specific gap within the plasmid
backbone using nicking restriction enzymes and filling in the gap with a synthetic
oligodeoxynucleotide containing the platinated DNA adduct (Fig. 1).2, 3 The pGLuc6temG
vector was derived from a commercial pCMV-GLuc construct with the intention of
preparing a plasmid containing a site-specific monofunctional dG-Pt lesion4 as a probe for
live cell experiments. pCMV-GLuc was modified by PCR-mediated deletion to remove the
SV40 origin of replication and BspQI restriction sites,5 after which it was directionally
ligated with a synthetic 30-bp insertion sequence between HindIII and BamHI sites to yield
pGLuc6temG. This insertion sequence contains unique enzyme restriction sites that can be
nicked in tandem by Nt.BspQI 16-bases apart on the template strand of the plasmid (Fig. 2).
Nt.BspQI is the variant of BspQI that recognizes GCTCTTC(1/4) but is engineered to cleave
only one strand of the recognition sequence, specifically at GCTCTTCN↓. Removal of the
16-base nicked strand was achieved by annealing with its complement in high molar excess
followed by purification using diafiltration. As part of the vector design, a unique BstAPI
restriction site was positioned within the insertion sequence such that it overlaps with the
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location of the intended modified base. In this manner, the modified base can be readily
detected by determining the extent to which BstAPI can linearize the plasmid. The gap is
filled-in by ligating a 16-base synthetic oligodeoxynucleotide to the plasmid construct with
T4 DNA ligase. The covalently closed plasmid product thus formed can be readily purified
from the open circular gapped precursor by agarose gel electrophoresis.
We previously reported a strategy for building oligodeoxynucleotides containing purine-rich
sequences that are difficult to platinate site-specifically by incorporating 7-deaza-purine
bases into their sequences.6 These bases are isosteric analogs of parent purines in which the
N7 atom is replaced by a C–H unit (Fig. 3). They exhibit altered chemical reactivity and
stability while maintaining similar biological functionality.7, 8 For example, 7-deaza-dGTP
can substitute for dGTP to clone GC-rich genomic regions to reduce formation of secondary
DNA structures that would inhibit conventional PCR. Cisplatin preferentially reacts at the
N7 positions of the purine heterocyclic rings, and platination at unwanted purine sites can be
averted by substituting them with their corresponding 7-deaza-purine analogs. The 16-base
oligodeoxynucleotide strand 5’-CATCCTCTGCTCTTCC required to fill in gapped
pGLuc6temG contains dA at the 2-position and dG at the 9-position. We reasoned that, by
replacing dA with 7-deaza-dA on the 16-base strand, we could improve the yield and purity
of the monofunctional dG-platinated oligodeoxynucleotide preparation by blocking
platination at the dA site. We sought to determine whether this minor base modification
would adversely affect the subsequent preparation and analysis of the resultant plasmid.
The 16-base oligodeoxynucleotide insertion strands containing either dA or 7-deaza-dA,
designated as 16-is and 16-deaza-is respectively, were prepared by conventional
phosphoramidite methods and purified by anion-exchange-HPLC.9 By analyzing the RP-
HPLC trace of the enzymatic digests by nuclease S1 and calf intestinal phosphatase (CIP),
the two oligodeoxynucleotides were readily distinguished based on the different retention
times of dA and 7-deaza-dA (Fig. 3). The 7-deaza-dA nucleotide is more hydrophobic than
dA and binds more strongly to the reverse phase C18 column, resulting in a longer retention
time.
Insertion of the phosphorylated 16-base oligodeoxynucleotide strands into the gapped
plasmid was facile and ligation proceeded in high yield. Gel electrophoretic analysis of
isolated gapped pGLuc6temG treated with T4 DNA ligase revealed low levels of covalently
closed circular DNA, indicating that the plasmid was effectively gapped. By comparison, the
levels of covalently closed plasmid product formation were high when 16-is and 16-deaza-is
were added, 73% and 72% respectively (Fig. 5), indicating that the 7-deaza-dA modification
did not affect the ligation efficiency of inserts to the gapped plasmid. Ligation of 16-is and
16-deaza-is into gapped pGLuc6temG carried out on a preparative scale yielded covalently
closed plasmid products, designated as pGLuc6tem + is and pGLuc6tem+deaza-is
respectively, in moderate yields. Analysis of the synthesized plasmids was performed by
treating them with BstAPI and the results were compared to those for the parent
pGLuc6temG plasmid isolated from bacterial culture. Both 2-dA and 9-dG are situated
within the recognition sequence of BstAPI (GCANNNN↓NTGC). Unhindered BstAPI
cleaves the pGLuc6temG vector quantitatively at the insertion sequence to yield exclusively
linearized plasmid (lin). Both parent pGLuc6temG and pGLuc6temG+is are susceptible to
BstAPI cleavage, but pGLuc6temG+deaza-is, which contains a site-specific 7-deaza-dA
nucleotide, could not be linearized (Fig. 6).
The ability of 7-deaza-purine bases to impede restriction enzyme digestion has been
previously demonstrated. In one study, EcoRI (G↓AATTC) cleaved the octadeoxynucleotide
duplex substrate d(GGAATTCC) cleanly but not d(GGAATCC), where G denotes the
position of 7-deaza-dG.10 In another report, PCR was carried out on bacteriophage λ DNA
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and pUC19 plasmid using 7-deaza-dGTP in place of dGTP to prepare PCR fragments
having exclusively 7-deaza-dG.11 The PCR-amplified products isolated were resistant to a
number of Type IIP restriction enzymes containing at least a dG in the recognition sequence,
including EcoRI, BamHI, and AccI. Out of the 13 enzymes tested, only 3 were able to
cleave the 7-deaza-dG enriched DNA, but no discernible pattern could be established linking
the spatial position of dG within the recognition sequence to the susceptibility of enzyme
cleavage.
Our system differs from the ones in these earlier reports in that the DNA substrate is a
covalently closed plasmid containing a single-atom, site-specific base modification at a
unique restriction site. Structurally, pGLuc6temG+deaza-is differs from pGLuc6temG+is
only by the replacement of N7 with a C–H unit at one of the dA in the recognition sequence.
This substitution is sufficient to prevent linearization by BstAPI, implicating an important
role of N7-dA for its activity. Since BstAPI recognizes the interrupted GCANNNN↓NTGC
sequence, but cuts between the fourth and fifth unspecified base,12 its inability to cleave the
7-deaza-dA-containing plasmids stems from the failure to recognize the modified base. This
result suggests important protein-DNA interactions between the DNA-binding motif and
N7-dA in the recognition sequence. Restriction enzymes form a highly cooperative H-
bonding network with the bases as well as the sugar-phosphate backbone in their recognition
sequence, giving rise to specific protein-DNA interactions.13 BglI, for example, exhibits
similar restriction characteristics as BstAPI because it also recognizes a discontinuous 11-bp
DNA sequence (GCCNNNN↓NGGC) and cleaves between the fourth and fifth unspecified
base to leave 3-bp 3’-overhangs. Crystallographic studies of BglI bound to a 17-base DNA
substrate revealed numerous contacts between the enzyme recognition motif with N7-dG on
both strands of the DNA substrate at the recognition site via H-bonding with arginine and
lysine residues.14 It is plausible that disruption of this intricate network by removal of a N7-
dA contact point severely affects the ability of BstAPI to stably bind at its recognition site.
Therefore, this technique of controlling and reprogramming a plasmid vector at the level of a
single nucleotide level can used to probe highly specific enzyme-DNA interactions.
In summary, site-specific modification of a mammalian expression vector was accomplished
by replacing a short single-stranded sequence on the plasmid DNA with a synthetic
oligodeoxynucleotide containing the modified base. The N7-dA atom at the BstAPI
restriction site was converted to a C–H unit, which rendered the modified plasmid resistant
to enzymatic cleavage by BstAPI. The present study extends the investigation of DNA-
based structure-activity relationships by a systematic alteration of a nucleotide at known or
postulated recognition sites. For example, the effects of the sugar-phosphate backbone on
site recognition could be studied by replacing phosphate linkages with phosphothioate ones.
In principle, site-specific programming of a plasmid can be easily carried out as long as the
modifiednucleotide can be synthesized as part of the oligodeoxynucleotide insert. We
anticipate that the method outlined will have broad applicability for mechanistic and
biotechnological studies.
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Fig. 1.
Overall scheme for preparing site-specifically modified plasmids.
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Fig. 2.
DNA sequence of the insertion region in pGLuc6temG vector; the position of the intended
strand for insertion is depicted in boldface font.
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Fig. 3.
Chemical structures of purine deoxynucleosides (left) compared to their 7-deaza-analogs
(right).
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Fig. 4.
HPLC chromatogram of enzymatic digestion of 16-base oligodeoxynucleotide strands by
nuclease S1 and CIP (peak demarcated by an asterisk is an impurity). dA\ is the deaza base.
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Fig. 5.
Ligation experiment of gapped pGLuc6temG in presence of different inserts with T4 DNA
Ligase at 16°C for 12 h; gapped pGLuc6temG alone (lane 1), plasmid + 16-is (lane 2),
plasmid + 16-deaza-is (lane 3).
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Fig. 6.
Restriction analysis of site-specifically modified plasmids with BstAPI; undigested parent
pGLuc6temG (lane 1), pGLuc6temG+is (lane 2) and pGLuc6temG+deaza-is (lane 3), and
BstAPI-digest of parent pGLuc6temG (lane 4), pGLuc6temG+is (lane 5) and pGLuc6temG
+deaza-is (lane 6).
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